Lymphocytic bronchiolitis is associated with inadequate suppression of blood T-cell granzyme B, IFN-γ, and TNF-α
Date
2010
Authors
Hodge, G.
Hodge, S.
Liew, C.
Chambers, D.
Hopkins, P.
Reynolds, P.
Holmes, M.
Editors
Advisors
Journal Title
Journal ISSN
Volume Title
Type:
Journal article
Citation
Transplantation, 2010; 89(10):1283-1289
Statement of Responsibility
Greg Hodge, Sandra Hodge, Chien Li-Liew, Daniel Chambers, Peter Hopkins, Paul N. Reynolds, Mark Hodge
Conference Name
Abstract
Background. Lymphocytic bronchiolitis (LB) has been shown to be an important factor for the subsequent development of obliterative bronchiolitis (OB). We have previously shown that OB, which limits long-term survival after lung transplantation, is associated with lack of suppression of peripheral blood T-cell granzyme B, interferon (IFN)-[gamma], and tumor necrosis factor (TNF)-[alpha]. However, the role of these proinflammatory mediators in LB is unknown. We hypothesized that these proinflammatory mediators may also be increased during LB episodes despite standard immunosuppression regimens. Methods. T-cell intracellular cytokine profiles and granzyme B were studied in whole blood, bronchoalveolar lavage samples, and bronchial brushings from stable lung transplant patients with LB and from healthy controls, using multiparameter flow cytometry. Results. There was a significant increase in peripheral blood T-cell granzyme B and CD8+ T-cell IFN-[gamma] and TNF-[alpha] in patients with LB compared with control and stable groups and a decrease in CD25+CD127-CD3+CD8- T regulatory cells in stable and LB transplant patients compared with controls. No changes were noted in the airways. Conclusions. LB is associated with inadequate suppression of peripheral blood T-cell granzyme B, IFN-[gamma], and TNF-[alpha]. Drugs that effectively reduce these proinflammatory mediators may improve current protocols for treating LB and possibly reduce subsequent progression to OB in lung transplant patients.
School/Discipline
Dissertation Note
Provenance
Description
Access Status
Rights
(C) 2010 Lippincott Williams & Wilkins, Inc.